医疗保险与制药创新的关系:基于元分析的经验研究
Chenchen Fan1, Xiaoting Song1, Chunyan Li1
1Shanghai International College of Intellectual Property, Tongji University, Shanghai 200092, China.
Healthcare (Basel, Switzerland)
|November 24, 2023
概括
医疗保险大力促进药品创新,公共计划比商业计划更有影响. 这种相关性受到各种因素的影响,为医疗保健和药物开发提供了洞察力.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 创新研究 研究 创新研究
背景情况:
- 对医疗保险对制药创新的影响越来越感兴趣.
- 在现有文献中缺乏共识和定量证据.
- 需要了解医疗保险与制药创新关系的规模.
研究的目的:
- 使用元分析量化评估医疗保险对制药创新的影响.
- 探索影响这种关系的调节因素.
- 为未来的研究提供基于机制的理解.
主要方法:
- 来自14个独立研究样本的202个观察结果的元分析.
- 医疗保险对药物创新的利用回归系数作为效应大小.
- 分析了国家,数据范围,期刊类型,影响因子,保险类型和研究视角的缓和效应.
主要成果:
- 在医疗保险和制药创新之间发现了强烈的正相关性 (r = 0.367).
- 与商业医疗保险相比,公共医疗保险表现出更强的积极影响.
- 对包括原产国和保险类型在内的几个因素,确定了显著的缓解效应.
结论:
- 医疗保险对制药创新产生了重大和积极的影响.
- 公共医疗保险在推动制药创新的过程中发挥了更为重要的作用.
- 调查结果为医疗保健政策和制药发展战略提供了关键的见解.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Pharmacovigilance
857
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
857


